tiprankstipranks
Trending News
More News >
PharmaCielo (PCLOF)
OTHER OTC:PCLOF
US Market

PharmaCielo (PCLOF) Financial Statements

Compare
90 Followers

PharmaCielo Financial Overview

PharmaCielo's market cap is currently $5.63M. The company's EPS TTM is $0.001465604; its P/E ratio is 5.19; PharmaCielo is scheduled to report earnings on March 2, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Jun 24Mar 23Mar 22Mar 21
Income Statement
Total RevenueC$ 3.48MC$ 1.54MC$ 5.31MC$ 1.94MC$ 2.65M
Gross ProfitC$ 730.88KC$ -1.37MC$ 827.06KC$ -4.31MC$ -6.80M
Operating IncomeC$ 0.00C$ -9.70MC$ -11.46MC$ -25.46MC$ -43.12M
EBITDAC$ -4.60MC$ -12.19MC$ -10.50MC$ -24.84MC$ -41.55M
Net IncomeC$ -9.14MC$ -16.30MC$ -16.04MC$ -26.92MC$ -44.26M
Balance Sheet
Cash & Short-Term InvestmentsC$ 147.94KC$ 62.18KC$ 325.98KC$ 5.63MC$ 9.61M
Total AssetsC$ 18.39MC$ 22.29MC$ 25.12MC$ 35.96MC$ 44.02M
Total DebtC$ 20.52MC$ 18.31MC$ 12.59MC$ 8.43MC$ 4.47M
Net DebtC$ 20.38MC$ 18.25MC$ 12.41MC$ 3.09MC$ -4.39M
Total LiabilitiesC$ 25.91MC$ 23.97MC$ 18.72MC$ 16.63MC$ 17.78M
Stockholders' EquityC$ -7.52MC$ -1.68MC$ 6.39MC$ 19.33MC$ 26.25M
Cash Flow
Free Cash FlowC$ -1.97MC$ -5.17MC$ -10.23MC$ -21.21MC$ -28.00M
Operating Cash FlowC$ -1.97MC$ -5.15MC$ -9.71MC$ -20.07MC$ -22.56M
Investing Cash FlowC$ 41.14KC$ 391.64KC$ -725.49KC$ -1.66MC$ -5.57M
Financing Cash FlowC$ 2.02MC$ 4.63MC$ 5.30MC$ 18.21MC$ 23.32M
Currency in CAD

PharmaCielo Earnings and Revenue History

PharmaCielo Debt to Assets

PharmaCielo Cash Flow

PharmaCielo Forecast EPS vs Actual EPS